Can "the Berlin Patient’s" Cure Be Replicated?

The amfAR-funded European ICISTEM research consortium is studying the key elements of this so-far singular cure.

• Neutrophils: A Deadly, if Delicate, Killer
• HIV in the Brain
• Where Are We in HIV Vaccine Research?
• New Findings Point to Power of Antibodies
• A Potential New Target for Eradication of HIV Reservoirs

Big Data and the Opioid Epidemic

Public health and policy experts recently gathered to discuss how data can help inform national and local responses to mitigate the epidemic.

• Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers
• Combating the HIV, Hep C and Opioid Epidemic: Policy Recommendations
• amfAR Study Assesses Impact of Medicaid Expansion on the Opioid Epidemic

PERSPECTIVES: Are integrase inhibitors the solution to HIV drug resistance in the Asia-Pacific region?

Four regional experts share their views on the role of this HIV drug class in treatment regimens.

• Why Has Asia Fallen Behind on HIV/AIDS?
• Hepatitis C: Policy Recommendations for Addressing a Growing Epidemic
• Assessing Failing Second-Line HIV Treatment Regimens: the TASER-2 Study

Preparing for Potential Game Changers

amfAR has produced a series of reports that describe the critical issues that must be navigated to make these potentially game-changing new products available for people living with HIV or vulnerable to infection.

amfAR featured in New York Times Editorial

“An Opioid Crisis Foretold” chronicles the history of the country’s opioid epidemic, describes the challenges in making addiction treatment more accessible to those who need it, and notes the similarities to the response to HIV/AIDS at the height of the epidemic.

Innovations

The latest edition of amfAR’s biannual newsletter covers research, policy, TREAT Asia, and event news, and includes a special tribute to Dr. Mathilde Krim.